0
0
heart
A recent study analyzing data across 21 regions has highlighted a concerning rise in heart disease-related fatalities globally. The research, conducted by experts from the National Institutes of Health and Institute for Health Metrics and Evaluation (IHME) at the University of Washington, underscores the high burden of deaths attributed to heart-related illnesses, with regions across Asia, Europe, Africa, and the Middle East being the most affected.
Key Findings:
- Heart disease-related deaths escalated from 12.4 million in 1990 to a staggering 19.8 million in 2022, marking a concerning trend of increasing fatalities associated with these conditions.
- Ischemic heart disease remains the leading cause of cardiovascular disease (CVD) mortality globally, with an age-standardized rate of approximately 110 deaths per 100,000 population, followed by brain hemorrhage and ischemic stroke.
- High blood pressure, elevated cholesterol levels, dietary risks, and air pollution emerged as leading contributors to these alarming mortality rates.
Regional Insights:
- The study pinpointed regions such as Central Asia, Eastern Europe, North Africa, and the Middle East with the highest mortality rates attributed to high systolic blood pressure.
- Similar concerns were raised regarding heart disease burdens linked to dietary risks in Central Asia, Oceania, and parts of North Africa and the Middle East.
Author Perspectives: George A. Mensah, director at the National Heart, Lung, and Blood Institute (NHLBI), emphasized the importance of using localized data to drive community-specific actions for fostering heart-healthy societies. Gregory A. Roth, senior author of the paper, stressed the preventable nature of many cardiovascular diseases, highlighting inexpensive and effective treatments available to tackle these ailments.
Global Implications:
- Eastern Europe displayed the highest total CVD death rates at 553 deaths per 100,000 population, while Australasia reported the lowest rates at 122.5 deaths per 100,000 individuals.
- The study serves as an update to the Global Burden of Diseases (GBD) Study 2022, offering insights into modifiable cardiovascular risk factors and recent advancements in prevention strategies.
The research, published in the Journal of the American College of Cardiology, underscores the urgent need for targeted interventions to mitigate the escalating burden of heart disease-related mortality worldwide. This comprehensive analysis serves as a crucial resource for informing and advancing strategies aimed at preventing and treating cardiovascular diseases globally.
